1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
2. Umezawa H, Takeuchi T, Nitta K, Yamamoto T, Yamaoka SS. An anti-tumor substance produced by streptomyces. J Antibiot (Tokyo). 1953;6:101
3. Uehara Y, Hori M, Takeuchi T, Umezawa H. Screening of agents which convert ‘transformed morphology’ of Rous sarcoma virus-infected rat kidney cells to ‘normal morphology’: identification of an active agent as herbimycin and its inhibition of intracellular src kinase. Jpn J cancer Res: Gann. 1985;76:672–5.
4. Uehara Y, Hori M, Takeuchi T, Umezawa H. Phenotypic change from transformed to normal induced by benzoquinonoid ansamycins accompanies inactivation of p60src in rat kidney cells infected with Rous sarcoma virus. Mol Cell Biol. 1986;6:2198–206.
5. Imoto M, Umezawa K, Isshiki K, Kunimoto S, Sawa T, Takeuchi T, et al. Kinetic studies of tyrosine kinase inhibition by erbstatin. J Antibiot. 1987;40:1471–3.